drugset / Trial / NCT00042146

Behavioral and Pharmacological Treatment for Insomnia

NCT00042146

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (Ambien®), for chronic insomnia.

Timeline

Start
2001-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule 10 mg